Article

Cost of Hepatitis C Antivirals May Keep Patients Away Tops SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

5. Toxic Components of Fire Ant Venom Reduce Inflammation in Psoriasis

Findings may lead to future treatments for patients with psoriasis and psoriatic arthritis. Read more…

4. First Predictive Model of Inflammatory Bowel Disease Developed

Study findings could lead to new treatment options for patients with IBD in the future. Read more…

3. Poor Adherence to Hormone Therapy Observed in Breast Cancer Survivors Taking Opioids

Adjuvant endocrine therapy can prevent cancer recurrence but can result in painful side effects. Read more…

2. Repurposing Drugs for Cancer Treatment

Many researchers are interested in looking at FDA-approved drugs that could potentially be repositioned for use in cancer treatment. Read more…

1. Cost of Hepatitis C Antivirals May Keep Patients Away

Limited proportion of patients with chronic hepatitis C virus received antiviral treatment before the widespread use of direct-acting antivirals. Read more…

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards